Status:
COMPLETED
Mangos to Reduce Cardiometabolic Risk Markers
Lead Sponsor:
California State Polytechnic University, Pomona
Conditions:
Healthy
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
This research study will determine the effects of mango consumption on blood pressure, body weight, dietary nutrient/pattern changes, total cholesterol, LDL-cholesterol, VLDL-cholesterol, triglyceride...
Detailed Description
Cardiovascular disease (CVD) is the leading cause of death in the United States and worldwide. Risk factors for CVD include, obesity, high serum concentrations of low-density lipoprotein (LDL) cholest...
Eligibility Criteria
Inclusion
- Apparently healthy students (18 to 40 years)
- Attend California State Polytechnic University, Pomona
- Moderately elevated blood pressure (systolic greater than 120 mm Hg or diastolic greater than 80 mm Hg) and/or LDL-cholesterol (greater than 100 mg/dL)
Exclusion
- Smokers
- Pregnancy
- Any medical issues
- Allergies or dislike of mangos
- Allergies to wheat, milk, eggs, and/or soy
Key Trial Info
Start Date :
September 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 12 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06029647
Start Date
September 18 2023
End Date
September 12 2024
Last Update
February 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
California State Polytechnic University, Pomona
Pomona, California, United States, 91768